Dr. Fleshner's clinical practice is in urologic oncology with research interests in prostate and bladder cancer.
Age differences in patient-reported psychological and physical distress symptoms in bladder cancer patients - A Cross Sectional Study.
Urology. 2019 Sep 02;:
Switching from a GnRH agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis.
Can Urol Assoc J. 2019 Jul 23;:
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2019 Jun 25;:
Urology. 2019 Jul 11;:
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
PLoS Med. 2019 Jul;16(7):e1002847
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
Eur Urol Oncol. 2019 May;2(3):231-238
Negative predictive value of prostate multi-parametric magnetic resonance imaging among men with negative prostate biopsy and elevated PSA - a clinical outcome retrospective cohort study.
J Urol. 2019 Jun 12;:101097JU0000000000000388
J Urol. 2019 Jun 05;:10109701JU00005585483448439
J Natl Cancer Inst. 2019 Jun 04;:
J Urol. 2019 08;202(2):325
Martin Barkin Chair, Division of Urology, Department of Surgery, University of Toronto
Professor, Department of Surgery, University of Toronto